Showing 9061-9070 of 20877 results for "".
Indications for Percutaneous Interventions
https://reachmd.com/programs/clinicians-roundtable/indications-for-percutaneous-interventions/371/Dr. Elizabeth Holper, an interventional cardiologist from UT Southwestern, discusses the indications for percutaneous interventions for coronary artery disease and the long term outcomes.HIV/AIDS-Epidemiology, Prevention and Intervention
https://reachmd.com/programs/clinicians-roundtable/hivaids-epidemiology-prevention-and-intervention/369/Dr. Paul Sax, Clinical Director of the HIV Program and Division of Infectious Diseases, Brigham and Women's Hospital and Associate Professor of Medicine at Harvard Medical School discusses the changes in patterns and trends in the epidemiology of HIV/AIDS.Calcium Score and its Use in Diagnosis
https://reachmd.com/programs/clinicians-roundtable/calcium-score-and-its-use-in-diagnosis/180/Dr. Raggi discusses tests that identify a patient's calcium score and the utility of using it when diagnosing a patient.Predicting Outcomes in IBD with Fecal Biomarkers
https://reachmd.com/programs/gi-insights/predicting-outcomes-in-ibd-with-fecal-biomarkers/32328/Read about recent findings on fecal biomarkers that can help predict complications in patients with inflammatory bowel disease.Improving CRC Screening Uptake: An Integrated Approach
https://reachmd.com/programs/clinicians-roundtable/increase-crc-screening-uptake-integrated/56445/A recent retrospective study evaluated how combining shared decision making and EHR-enabled workflow optimization impacted colorectal cancer (CRC) screening adherence among patients aged 45 and older. Learn more as Dr. Mallik Greene dives into the details and explains how this approach could imprSteroidal vs Nonsteroidal MRAs: Implications for Heart Failure Care
https://reachmd.com/programs/heart-matters/steroidal-vs-nonsteroidal-mras-implications-for-heart-failure-care/54802/Mineralocorticoid receptor antagonists (MRAs) play a key role in heart failure management, with differences between steroidal and nonsteroidal agents having the power to shape treatment decisions. Understanding these pharmacologic distinctions and clinical impacts can help optimize patient outcomesUnderstanding iMCD Through RNA Sequencing
https://reachmd.com/programs/project-oncology/understanding-imcd-through-rna-sequencing/26403/Explore how gene expression in idiopathic multicentric Castleman disease can help improve diagnostic and therapeutic strategies.Managing Psoriasis Flare-Ups: The Influence of Ultra-Processed Foods
https://reachmd.com/programs/spotlight-psoriasis/managing-psoriasis-flare-ups-the-influence-of-ultra-processed-foods/32444/Ultra-processed foods may exacerbate flare-ups in patients with psoriasis. Read about a recent study and its findings on this potential connection.Tailoring Inflammatory Bowel Disease Care: Selection Criteria and Timing
https://reachmd.com/programs/gi-insights/tailoring-inflammatory-bowel-disease-care-selection-criteria-and-timing/35591/As the advanced treatment landscape for inflammatory bowel disease continues to expand, selecting the right therapies has become more complex, with efficacy, safety, patient preferences, disease phenotypes, and more as factors to consider. Learn how to effectively navigate these therapeutic optionsLiving Well with IBD: Proactive Health Maintenance Strategies
https://reachmd.com/programs/gi-insights/living-well-with-ibd-proactive-health-maintenance-strategies/18013/Join us as we explore how we can optimize the health of our patients with IBD using strategies that go beyond the treatment of symptoms and disease.